Alexandru Stieber/LinkedIn
Dec 1, 2025, 15:32
Alexandru Stieber on a Curious Finding: GLP-1 RAs and the Risk of Optic Neuropathy
Alexandru Stieber, Internal Medicine Resident at SUUMC Bucharest, posted on LinkedIn:
“A very curious research revealing a possible link between the use of GLP-1 receptor antagonists such as semaglutide or liraglutide and the risk of developing nonarteritic ischemic anterior optic neuropathy, current findings which support previous studies on the matter and that nuance the uses of such therapeutic agents.”
Title: GLP-1 RAs and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Older Patients With Diabetes
Authors: Kin Wah Fung, Fitsum Baye, Seo H. Baik, Clement J. McDonald
Read full article here.
Stay updated with Hemostasis Today.
-
Dec 1, 2025, 15:35Frailty’s Impact on Outcomes After Acute Myocardial Infarction
-
Dec 1, 2025, 15:33Elias Bouchi: Celebrating Hemostasis in EEMEA!
-
Dec 1, 2025, 15:32Empowering the Bleeding Disorders Community Through Data․ WFH Workshop Recap
-
Dec 1, 2025, 15:31Register for the Women with Bleeding Disorders Summit 2026! – EHC
-
Dec 1, 2025, 15:30Jim Hoffman on a Critical Question: Should We Track NETosis and Use Blood Purification in Heart Failure?
-
Dec 1, 2025, 15:27It’s Time for November’s Learning Update! – ISBT
-
Dec 1, 2025, 15:26Marilena Vrana: “Meet Me in Milan” Should Be the Global Plasma Community’s Pass-Along Catchphrase
-
Dec 1, 2025, 15:25Maartje van den Biggelaar: LSBR Awarded Our Consortium the LSBR Anniversary Grant of €1.6 Million to Launch HemoTwin-BD
-
Dec 1, 2025, 15:24Dr Aaron Akpu Philip on the Front Lines: Supporting the National Blood Drive with Lifeblood and AIMA